MoneyWorks4Me

Gufic Biosciences - Quaterly Results

29 May 2024 Evaluate
The revenue for the March 2024 quarter is pegged at Rs. 1949.94 millions, about 12.69% up against Rs. 1730.36 millions recorded during the year-ago period.A slim rise of 10.73% was recorded in the Net profit for the quarter ended March 2024 to Rs. 200.47  millions  From Rs. 181.05 millions.OP of the company witnessed a marginal growth to 351.09 millions from 327.72 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1949.94 1730.36 12.69 8066.66 6906.21 16.80 8066.66 6906.21 16.80
Other Income 8.81 6.23 41.41 21.77 25.74 -15.42 21.77 25.74 -15.42
PBIDT 351.09 327.72 7.13 1480.48 1372.25 7.89 1480.48 1372.25 7.89
Interest 36.47 29.22 24.81 153.60 82.23 86.79 153.60 82.23 86.79
PBDT 314.62 298.50 5.40 1326.88 1290.02 2.86 1326.88 1290.02 2.86
Depreciation 43.42 59.18 -26.63 170.17 222.81 -23.63 170.17 222.81 -23.63
PBT 271.20 239.32 13.32 1156.71 1067.21 8.39 1156.71 1067.21 8.39
TAX 70.73 58.27 21.38 295.36 270.16 9.33 295.36 270.16 9.33
Deferred Tax -2.27 -3.73 -39.14 31.66 -11.94 -365.16 31.66 -11.94 -365.16
PAT 200.47 181.05 10.73 861.35 797.05 8.07 861.35 797.05 8.07
Equity 100.28 96.94 3.45 100.28 96.94 3.45 100.28 96.94 3.45
PBIDTM(%) 18.01 18.94 -4.93 18.35 19.87 -7.63 18.35 19.87 -7.63
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..